Takeda Pharmaceutical's Other Non-Current Assets rose 361.74% to $505.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $505.4 million, marking a year-over-year increase of 361.74%. This contributed to the annual value of $461.4 million for FY2025, which is 2992.38% up from last year.
Latest data reveals that Takeda Pharmaceutical reported Other Non-Current Assets of $505.4 million as of Q4 2025, which was up 361.74% from $478.7 million recorded in Q3 2025.
In the past 5 years, Takeda Pharmaceutical's Other Non-Current Assets registered a high of $948.0 million during Q1 2021, and its lowest value of $345.6 million during Q1 2024.
Over the past 5 years, Takeda Pharmaceutical's median Other Non-Current Assets value was $496.6 million (recorded in 2025), while the average stood at $575.0 million.
Per our database at Business Quant, Takeda Pharmaceutical's Other Non-Current Assets tumbled by 3297.36% in 2023 and then surged by 5530.35% in 2024.
Takeda Pharmaceutical's Other Non-Current Assets (Quarter) stood at $700.7 million in 2021, then plummeted by 32.54% to $472.6 million in 2022, then decreased by 21.7% to $370.1 million in 2023, then skyrocketed by 31.81% to $487.8 million in 2024, then increased by 3.62% to $505.4 million in 2025.
Its Other Non-Current Assets stands at $505.4 million for Q4 2025, versus $478.7 million for Q3 2025 and $473.8 million for Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value